From Information Chaos to Deal Intelligence: Building AI into the Biotech Investment Process
Wed, Sep 16
|
09:25 AM - 09:50 AM
121B
Session details:
- Explore why evaluating in-licensing opportunities, monitoring competitor pipelines, and building investment theses all face the same challenge: too many internal and external sources, workflows that do not scale, and the persistent risk of missing critical information.
- Hear a practitioner's perspective on building and scaling AI-enabled investment workflows, drawing on experience from both a publicly traded pharmaceutical royalty company and an independent AI-driven investment firm.
- Learn where traditional research and intelligence tools fell short, how to evaluate build-versus-buy decisions for research-intensive workflows, and what has genuinely changed against what remains hype
